JMJD5 Antikörper (AA 20-220)
-
- Target Alle JMJD5 Antikörper anzeigen
- JMJD5 (Jumonji Domain Containing 5 (JMJD5))
-
Bindungsspezifität
- AA 20-220
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser JMJD5 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Protein A Chromatography
- Immunogen
- A partial length recombinant JMJD5 protein (amino acids 20-220) was used as the immunogen for this antibody.
- Isotyp
- IgG
- Top Product
- Discover our top product JMJD5 Primärantikörper
-
anti-Jumonji Domain Containing 5 (JMJD5) (AA 36-63), (N-Term) antibody
JMJD5 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB24972 unconjugated
anti-Jumonji Domain Containing 5 (JMJD5) (AA 1-416) antibodyJMJD5 Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-Jumonji Domain Containing 5 (JMJD5) (AA 151-380) antibodyJMJD5 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Jumonji Domain Containing 5 (JMJD5) (AA 147-416) antibodyJMJD5 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Jumonji Domain Containing 5 (JMJD5) (N-Term) antibodyJMJD5 Reaktivität: Human, Meerschweinchen, Pferd, Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-Jumonji Domain Containing 5 (JMJD5) (AA 72-121) antibodyJMJD5 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Meerschweinchen, Pferd, Kaninchen, Affe, Huhn, Schwein WB Wirt: Kaninchen Polyclonal unconjugated
anti-Jumonji Domain Containing 5 (JMJD5) (C-Term) antibodyJMJD5 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Zebrafisch (Danio rerio), Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-Jumonji Domain Containing 5 (JMJD5) (Middle Region) antibodyJMJD5 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Meerschweinchen, Pferd, Zebrafisch (Danio rerio), Hund, Kaninchen WB, ChIP Wirt: Kaninchen Polyclonal unconjugated
anti-Jumonji Domain Containing 5 (JMJD5) (C-Term) antibodyJMJD5 Reaktivität: Human, Maus, Ratte WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
anti-Jumonji Domain Containing 5 (JMJD5) (AA 36-63), (N-Term) antibodyJMJD5 Reaktivität: Human WB, EIA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB: 2-4 μg/mL
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 0.5 mg/mL
- Buffer
- PBS containing 0.05 % BSA, PH 7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store the antibody at 4°C, stable for 6 months. For long-term storage, store at -20°C. Avoid repeated freeze and thaw cycles.
-
- Target
- JMJD5 (Jumonji Domain Containing 5 (JMJD5))
- Andere Bezeichnung
- JMJD5 (JMJD5 Produkte)
- Synonyme
- jmjd5 antikoerper, JMJD5 antikoerper, 3110005O21Rik antikoerper, Jmjd5 antikoerper, zgc:173863 antikoerper, zgc:91962 antikoerper, RGD1304823 antikoerper, lysine demethylase 8 antikoerper, jumonji domain containing 5 antikoerper, hypothetical protein antikoerper, lysine (K)-specific demethylase 8 antikoerper, KDM8 antikoerper, PTRG_02386 antikoerper, MCYG_00400 antikoerper, CC1G_13927 antikoerper, PGTG_16928 antikoerper, kdm8 antikoerper, Kdm8 antikoerper
- Hintergrund
- JMJD5 (Jumonji domain-containing protein 5) or commonly called as Lysine-specific demethylase 8 is a histone lysine demethylase that specifically demethylates dimethylated Lys 36 of histone H3 (H3K36me2) thereby activating the target gene. JMJD5 is important for G2/M phase cell cycle progression. JMJD5 is also a potential tumor suppression protein. JMJD5 helps in regulation of cancer proliferation by regulating cyclin-A1. JMJD5 has three isoforms (47, 24, 50 kDa), all localized in nucleus. JMJD5 is weakly expressed in most normal cells but highly expressed in breast cancer cells.
- Molekulargewicht
- 47 kDa
- Gen-ID
- 79831
- UniProt
- Q8N371
- Pathways
- Chromatin Binding
-
